140 related articles for article (PubMed ID: 25029565)
1. Type II transmembrane serine protease gene variants associate with breast cancer.
Luostari K; Hartikainen JM; Tengström M; Palvimo JJ; Kataja V; Mannermaa A; Kosma VM
PLoS One; 2014; 9(7):e102519. PubMed ID: 25029565
[TBL] [Abstract][Full Text] [Related]
2. Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.
Pelkonen M; Luostari K; Tengström M; Ahonen H; Berdel B; Kataja V; Soini Y; Kosma VM; Mannermaa A
BMC Cancer; 2015 May; 15():431. PubMed ID: 26014348
[TBL] [Abstract][Full Text] [Related]
3. Matriptase-2 gene (TMPRSS6) variants associate with breast cancer survival, and reduced expression is related to triple-negative breast cancer.
Tuhkanen H; Hartikainen JM; Soini Y; Velasco G; Sironen R; Nykopp TK; Kataja V; Eskelinen M; Kosma VM; Mannermaa A
Int J Cancer; 2013 Nov; 133(10):2334-40. PubMed ID: 23649491
[TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
5. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of IL10 and TNF alpha functional polymorphisms in premenopausal early-stage breast cancer patients.
Korobeinikova E; Myrzaliyeva D; Ugenskiene R; Raulinaityte D; Gedminaite J; Smigelskas K; Juozaityte E
BMC Genet; 2015 Jun; 16():70. PubMed ID: 26112140
[TBL] [Abstract][Full Text] [Related]
7. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
8. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
[TBL] [Abstract][Full Text] [Related]
9. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium.
Cai Q; Long J; Lu W; Qu S; Wen W; Kang D; Lee JY; Chen K; Shen H; Shen CY; Sung H; Matsuo K; Haiman CA; Khoo US; Ren Z; Iwasaki M; Gu K; Xiang YB; Choi JY; Park SK; Zhang L; Hu Z; Wu PE; Noh DY; Tajima K; Henderson BE; Chan KY; Su F; Kasuga Y; Wang W; Cheng JR; Yoo KY; Lee JY; Zheng H; Liu Y; Shieh YL; Kim SW; Lee JW; Iwata H; Le Marchand L; Chan SY; Xie X; Tsugane S; Lee MH; Wang S; Li G; Levy S; Huang B; Shi J; Delahanty R; Zheng Y; Li C; Gao YT; Shu XO; Zheng W
Hum Mol Genet; 2011 Dec; 20(24):4991-9. PubMed ID: 21908515
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
12. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
[TBL] [Abstract][Full Text] [Related]
13. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in centrobin and Nek2 are associated with breast cancer susceptibility in a Chinese Han population.
Wang H; Xie YT; Han JY; Ruan Y; Song AP; Zheng LY; Zhang WZ; Sajdik C; Li Y; Tian XX; Fang WG
Breast Cancer Res Treat; 2012 Nov; 136(1):241-51. PubMed ID: 23001753
[TBL] [Abstract][Full Text] [Related]
15. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
Padala C; Tupurani MA; Puranam K; Gantala S; Shyamala N; Kondapalli MS; Gundapaneni KK; Mudigonda S; Galimudi RK; Kupsal K; Nanchari SR; Chavan U; Chinta SK; Mukta S; Satti V; Hanumanth SR
PLoS One; 2017; 12(9):e0184448. PubMed ID: 28961241
[TBL] [Abstract][Full Text] [Related]
17. Previous GWAS hits in relation to young-onset breast cancer.
Shi M; O'Brien KM; Sandler DP; Taylor JA; Zaykin DV; Weinberg CR
Breast Cancer Res Treat; 2017 Jan; 161(2):333-344. PubMed ID: 27848153
[TBL] [Abstract][Full Text] [Related]
18. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
Cox DG; Simard J; Sinnett D; Hamdi Y; Soucy P; Ouimet M; Barjhoux L; Verny-Pierre C; McGuffog L; Healey S; Szabo C; Greene MH; Mai PL; Andrulis IL; ; Thomassen M; Gerdes AM; Caligo MA; Friedman E; Laitman Y; Kaufman B; Paluch SS; Borg Å; Karlsson P; Askmalm MS; Bustinza GB; ; Nathanson KL; Domchek SM; Rebbeck TR; Benítez J; Hamann U; Rookus MA; van den Ouweland AM; Ausems MG; Aalfs CM; van Asperen CJ; Devilee P; Gille HJ; ; ; Peock S; Frost D; Evans DG; Eeles R; Izatt L; Adlard J; Paterson J; Eason J; Godwin AK; Remon MA; Moncoutier V; Gauthier-Villars M; Lasset C; Giraud S; Hardouin A; Berthet P; Sobol H; Eisinger F; Bressac de Paillerets B; Caron O; Delnatte C; ; Goldgar D; Miron A; Ozcelik H; Buys S; Southey MC; Terry MB; ; Singer CF; Dressler AC; Tea MK; Hansen TV; Johannsson O; Piedmonte M; Rodriguez GC; Basil JB; Blank S; Toland AE; Montagna M; Isaacs C; Blanco I; Gayther SA; Moysich KB; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Ditsch N; Arnold N; Niederacher D; Sutter C; Gadzicki D; Fiebig B; Caldes T; Laframboise R; Nevanlinna H; Chen X; Beesley J; Spurdle AB; Neuhausen SL; Ding YC; Couch FJ; Wang X; Peterlongo P; Manoukian S; Bernard L; Radice P; Easton DF; Chenevix-Trench G; Antoniou AC; Stoppa-Lyonnet D; Mazoyer S; Sinilnikova OM;
Hum Mol Genet; 2011 Dec; 20(23):4732-47. PubMed ID: 21890493
[TBL] [Abstract][Full Text] [Related]
19. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
20. Circadian Gene Polymorphisms Associated with Breast Cancer Susceptibility.
Lesicka M; Jabłońska E; Wieczorek E; Pepłońska B; Gromadzińska J; Seroczyńska B; Kalinowski L; Skokowski J; Reszka E
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
